Related Experiment Videos

[The use of holoxan (iphosphamide) in malignant tumors]

N I Perevodchikova, N F Orel, N V Trofimova

Voprosy Onkologii

|January 1, 1990

Abstract:

A clinical trial of holoxan in combination with a urological protector--uromitexan--was carried out. Response was observed in 26.3% of patients with lung cancer. The drug was effective in cases of soft tissue sarcoma and Ewing's sarcoma.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

[Genetic characterization of populations of the Volga-Ural region according to the variability of the Y-chromosome].

Genetika·2015

Effects of fullerenol C₆₀(OH)₂₄ on erythropoiesis in vitro.

Bulletin of experimental biology and medicine·2014

[Which patients with ovarian cancer shows the combination of trabectedin with pegylated liposomal doxorubicin].

Vestnik Rossiiskoi akademii meditsinskikh nauk·2014

[The application of immunoglobulins for intravenous administration for the combined treatment of paratonsillar abscesses].

Vestnik otorinolaringologii·2012

[Study on efficacy and toxicity of new combined regimen "taxoter + cisplatin + 5-fluorouracil" in disseminated and locally-spread stomach cancer. Comparative analysis of tolerance and efficacy in patients younger and older than 65 years].

Advances in gerontology = Uspekhi gerontologii·2006

[Experience in treating elderly patients with disseminated stomach and colon cancer].

Advances in gerontology = Uspekhi gerontologii·2003

See all related articles